Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...
CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...
The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity.
7d
GlobalData on MSNNew life sciences facility at Wilmington Airport takes next step in constructionFrontier Scientific Solutions has announced progress on the development of its current good manufacturing practice (GMP) ...
Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
Once the Quality Power IPO allotment is finalised, investors can check their status on the official websites of BSE, NSE, or ...
The King’s College London Gene Therapy Vector Facility (GTVF) provides comprehensive GMP-grade viral vector manufacturing services. This includes Lentiviral Vector (LV), Retroviral Vector (RV) and ...
The observations are mainly procedural and do not indicate any data integrity issues, Piramal Pharma added in a regulatory ...
Royalarc Electrodes will launch its SME IPO on February 14, offering 30 lakh shares to raise Rs 36 crore. The price band is ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results